Edition:
United States

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

5.29USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$5.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,845
52-wk High
$23.50
52-wk Low
$3.43

Chart for

About

Innovate Biopharmaceuticals, Inc., formerly Monster Digital, Inc., is a clinical stage biotechnology company. The Company is focused on developing novel autoimmune and inflammation therapeutic drugs. Its lead drug candidate, larazotide acetate (INN-202) is a tight junction regulator. Its other products include INN-108 and... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $75.97
Shares Outstanding(Mil.): 14.36
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 180.40 17.28
EPS (TTM): -- -- --
ROI: -- -0.52 35.61
ROE: -- -3.30 17.17

Earnings vs. Estimates

No consensus analysis data available.